Smith & Nephew SNATS, Inc. (SNN)

Last Price: 39.31 (2020-09-18)

Company Description

Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $5.14B
Net Income (Most Recent Fiscal Year) $600.00M
PE Ratio (Current Year Earnings Estimate) 31.37
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) 5.89
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 3.56
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 12.64
Pre-Tax Margin (Trailing 12 Months) 14.46%
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) --
Current Ratio (Most Recent Fiscal Quarter) 2.18
Quick Ratio (Most Recent Fiscal Quarter) 1.04
Debt to Common Equity (Most Recent Fiscal Quarter) 0.50
Inventory Turnover (Trailing 12 Months) 0.85
Book Value per Share (Most Recent Fiscal Quarter) $11.76
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) $2.04
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 437.77M
Free Float 433.40M
Market Capitalization $17.65B
Average Volume (Last 20 Days) 0.25M
Beta (Past 60 Months) 0.55
Percentage Held By Insiders (Latest Annual Proxy Report) 1.00%
Percentage Held By Institutions (Latest 13F Reports) 9.12%
Annual Dividend (Based on Last Quarter) $0.90
Dividend Yield (Based on Last Quarter) 2.24%